Michael J. Fox Foundation for Parkinson's Research
126
15
20
80
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
8.7%
11 terminated/withdrawn out of 126 trials
87.9%
+1.4% vs industry average
7%
9 trials in Phase 3/4
46%
37 of 80 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (126)
Adaptive Deep Brain Stimulation to Improve Motor and Gait Functions in Parkinson's Disease
Role: collaborator
Movement State-dependent Adaptive DBS for PD
Role: collaborator
Neuroimaging of Parkinson's
Role: collaborator
Genotypic Influences on Network Progression in Parkinson's Disease
Role: collaborator
White Matter Distortion and Dementia Biomarkers in Normal Pressure Hydrocephalus (NPH)
Role: collaborator
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
Role: lead
Optimizing Vibrational Therapy to Improve Gait and Balance in Parkinson's Disease
Role: collaborator
Black and African Americans Connections to Parkinson's Disease (BLAAC PD)
Role: lead
Quantification of Phosphorylated Alpha-synuclein in Cutaneous Biopsies as a Prospective Biomarker in Parkinson's Disease
Role: collaborator
Longitudinal TSPO PET Imaging With [18F]DPA-714 in PPMI (PPMI DPA-714 PET Imaging)
Role: collaborator
Early Longitudinal Imaging in the Parkinson's Progressive Marker Initiative (PPMI) Using (18F)AV-133 (PPMI AV-133 Prodromal Imaging)
Role: lead
Study to Assess PDM608 in Healthy Adult Subjects
Role: collaborator
Utilizing Neural Signatures and Virtual Reality to Advance DBS Programming
Role: collaborator
Edmond J. Safra Accelerating Clinical Trials in Parkinson's Disease: A Multiarm Multi-stage Platform Trial
Role: collaborator
Safety, Tolerability and Exploratory Efficacy of EC5026 in Parkinson's Disease (STEP Study)
Role: collaborator
Use of a Non-Invasive Brainstem Neuromodulation Device to Improve Neurovascular Status in Parkinson's Disease
Role: collaborator
TURN-IT FOG: Improving Turning and Freezing of Gait in People With PD
Role: collaborator
A Novel Measurement Concept to Objectively Quantify Severity of Vocal and Speech Related Symptoms Associated With Parkinson's Disease
Role: collaborator
Evaluation of Tau-Pathology in Sporadic and LRRK2 Parkinson's Disease
Role: lead
Slow-SPEED-NL: Slowing Parkinson's Early Through Exercise Dosage-Netherlands
Role: collaborator